Project CBD speaks with Matt Elmes, PhD, director of new product development at CannaCraft, about his post-doctoral research on CBD, fatty acid transport molecules, and the endocannabinoid system.
From Wholistic Research & Education Foundation.
In this edition of Cannabis Conversations, Project CBD speaks with Dr. Paula Dall’Stella, a leading cannabis clinician in San Paolo, Brazil.
This activist is the reason you know about CBD. Now he’s telling the history behind the cannabinoid.
In this edition of Cannabis Conversations, Martin A. Lee speaks with Greg Gerdeman, neuroscientist, former professor, and chief science officer with 3 Boys Farms on the endocannabinoid system and the biology of wellness.
As you gaze upon these words, dear reader, a horde of alien marauders are ransacking all corners of the globe, chewing through the latest pharmaceutical defenses and leaving behind a gruesome trail of dead and weakened victims. According to a recent report by the World Health Organization (WHO), ferocious tribes of bacteria, parasites, viruses and fungi are on the rampage, and some are proving virtually invincible to the so-called “last resort” antibiotics.
In this edition of Cannabis Conversations, Project CBD director Martin A. Lee interviews Kelly Dunn & Josh Sarvis, British Columba cannabis farmers, about sustainable and regenerative growing practices.
Medical patients swear by it. Researchers are intrigued by it. Government regulators are flustered by it. And investors are head over heels for it. But what exactly is CBD oil?
In this edition of Cannabis Conversations, former municipal court judge Doug Bench discusses his transformation from ardent prohibitionist to medical cannabis advocate.
In this edition of Cannabis Conversations, Project CBD Director, Martin A. Lee, discusses the benefits of CBD, the “entourage effect” and the microbiome with Dr. Ethan Russo.
A Project CBD featured video, see how cannabis oil is extracted and produced.
Cannabis Conversations with cannabis pioneer Alice O’Leary Randall on the momentous court case that launched the medical marijuana movement.
In this installment of Cannabis Conversations, Dr. Ethan Russo discusses clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
Low-dose and high-dose treatments, protocols for chronic users, and the potential benefits of psychoactivity.
Cannabis Conversations video interview on the current landscape of pesticides regulation, pest management, and the need for further research.
Lab testing, safety protocols, adverse events reporting, and regulatory standards for the cannabis industry.
CBD-rich drug plants, disappearing landrace strains, and the future of cannabis farming.
The applications of cannabis as an alternative to traditional therapies for PTSD.
Using cannabis medicine for intractable epilepsy, cancer, autism, and mental health conditions.
Brain science, the neurobiology of stress, and moving away from the drug abuse paradigm.
Minor cannabinois and terpenes (quarterly Society of Cannabis Clinicians meeting).
Kevin McKernan on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine.”
A documentary film tells the story of the “father of cannabinoid medicine,” from his early days as a child of the Holocaust through his career as chief investigator into the world’s most misunderstood plant.
There are many ways to extract oil from the cannabis plant—each with its pros and cons. Some methods are safer and more effective than others. Cannabis oil made with neurotoxic solvents like butane and hexane may leave unsafe residues that compromise immune function and impede healing.
Project CBD is a California-based nonprofit dedicated to promoting and publicizing research into the medical uses of cannabidiol (CBD) and other components of the cannabis plant. We provide educational services for physicians, patients, industry professionals, and the general public.
Cannabidiol—CBD—is a cannabis compound that has significant medical benefits, but does not make people feel “stoned.” The fact that CBD-rich cannabis is non-psychoactive or less psychoactive than THC-dominant strains makes it an appealing option for many patients.